Boston Scientific CorporationSEC Filings
|
|
All SEC filings by Boston Scientific Corporation (BSX) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 3, 2026 | |
| 10-Q | Quarterly report | View Diff | May 1, 2026 | |
| ARS | Annual report to shareholders | Mar 18, 2026 | ||
| 10-K | Annual report | View Diff | Feb 17, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 3, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 1, 2025 | |
| 10-Q | Quarterly report | View Diff | May 1, 2025 | |
| ARS | Annual report to shareholders | Mar 19, 2025 | ||
| 10-K | Annual report | View Diff | Feb 18, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 1, 2024 |
Events
| 8-K | Boston Scientific Appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer | Oct 7, 2026 | ||
| 8-K | Current report | Sep 23, 2026 | ||
| 8-K | Current report | Sep 8, 2026 | ||
| 8-K | Current report | Aug 26, 2026 | ||
| 8-K | Boston Scientific Announces Results for Second Quarter 2026 | Jul 29, 2026 | ||
| 8-K | Current report | Jul 27, 2026 | ||
| 8-K | Other Events | May 18, 2026 | ||
| 8-K | Boston Scientific Announces Strategic Investment in Mirus Llc | May 18, 2026 | ||
| 8-K | Amendments to Articles of Incorporation or Bylaws | May 5, 2026 | ||
| 8-K | Boston Scientific Announces Results for First Quarter 2026 | Apr 22, 2026 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | May 8, 2026 | ||
| 425 | Business combination disclosure | Apr 22, 2026 | ||
| 424B3 | Prospectus supplement | Apr 1, 2026 | ||
| S-4/A | Registration of securities issued in business combination transactions | View Diff | Mar 30, 2026 | |
| 425 | Business combination disclosure | Mar 3, 2026 | ||
| S-4 | Registration of securities issued in business combination transactions | Feb 27, 2026 | ||
| 425 | Business combination disclosure | Feb 4, 2026 | ||
| 425 | Business combination disclosure | Jan 21, 2026 | ||
| 425 | Business combination disclosure | Jan 21, 2026 | ||
| 425 | Business combination disclosure | Jan 20, 2026 |
Proxies
| DEFA14A | Proxy Filing | Mar 18, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Mar 18, 2026 | |
| PRE 14A | Annual Meeting of Shareholders | View Diff | Mar 6, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Mar 19, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 19, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Apr 29, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 20, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 20, 2024 | |
| PRE 14A | Preliminary proxy | Mar 7, 2024 | ||
| DEFR14A | Revised proxy | Mar 22, 2023 |
Other
| SD | Conflict minerals disclosure | May 21, 2026 | ||
| EFFECT | Notice of effectiveness | Apr 2, 2026 | ||
| CORRESP | Correspondence with SEC | Mar 30, 2026 | ||
| UPLOAD | Letter from SEC | Mar 9, 2026 | ||
| SD | Conflict minerals disclosure | May 22, 2025 | ||
| SD | Conflict minerals disclosure | May 23, 2024 | ||
| SD | Conflict minerals disclosure | May 25, 2023 | ||
| SD | Conflict minerals disclosure | May 25, 2022 | ||
| SD | Conflict minerals disclosure | May 19, 2021 | ||
| SD | Conflict minerals disclosure | May 28, 2020 |
Ownership
| 4 | O'Connor Padraig Andrew | Sep 3, 2026 | ||
| 4 | Morano Susan E | Aug 26, 2026 | ||
| 4 | Woodworth Emily | Aug 12, 2026 | ||
| 4 | Monson Jonathan | Aug 11, 2026 | ||
| 4 | Habiger David C | Aug 7, 2026 | ||
| SC 13G/A | Fmr Llc Updates 3.1% Stake in Boston Scientific Corp | Aug 6, 2026 | ||
| 4 | Habiger David C | Aug 5, 2026 | ||
| 4 | Mahoney Michael F | Aug 5, 2026 | ||
| 4 | Ludwig Edward J | Aug 3, 2026 | ||
| 4 | Fitzgerald Joseph Michael | Aug 3, 2026 |